Anrotinib and Tirelizumab in First-line Treatment of RM-NPC

Name: Anrotinib and Tirelizumab in First-line Treatment of RM-NPC
License: Public Domain

Zhongshan People's Hospital, Guangdong, China

ClinicalTrials.gov · Datasets · License: Public Domain

nasopharyngeal carcinoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 136326
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.